Nt-Probnp/Urine Hepcidin-25 Ratio and Cardiorenal Syndrome Type 1 in Patients with Severe Symptomatic Aortic Stenosis

References

• Ronco C , HaapioM, HouseAA, AnavekarN, BellomoR. Cardiorenal syndrome. J. Am. Coll. Cardiol.52(19), 1527–1539 (2008).
   PubMed Web of Science ®Google Scholar
• Witberg G , SteinmetzT, LandesUet al. Change in kidney function and 2-year mortality after transcatheter aortic valve replacement. JAMA Netw. Open4(3), e213296 (2021).
   PubMed Web of Science ®Google Scholar
• Patel KK , ShahSY, ArrigainSet al. Characteristics and outcomes of patients with aortic stenosis and chronic kidney disease. J. Am. Heart Assoc.8(3), e009980 (2019).
   PubMed Web of Science ®Google Scholar
• Ronco C , CicoiraM, McCulloughPA. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J. Am. Coll. Cardiol.60(12), 1031–1042 (2012).
   PubMedGoogle Scholar
• Haase M , MüllerC, DammanKet al. Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib. Nephrol.182, 99–116 (2013).
   PubMed Web of Science ®Google Scholar
• Uduman J . Epidemiology of cardiorenal syndrome. Adv. Chronic Kidney Dis.25(5), 391–399 (2018).
   PubMed Web of Science ®Google Scholar
• Eren Z , OzverenO, BuvukonerE, KasparE, DegertekinM, KantarciG. A single-centre study of acute cardiorenal syndrome: incidence, risk factors and consequences. Cardiorenal. Med.2(3), 168–176 (2012).
   PubMed Web of Science ®Google Scholar
• Adachi Y , YamamotoM. OCEAN-SHD family. Chronic kidney disease and transcatheter aortic valve implantation. Cardiovasc. Interv. Ther.37(3), 458–464 (2022).
   PubMed Web of Science ®Google Scholar
• Gembillo G , ViscontiL, GiustiMAet al. Cardiorenal syndrome: new pathways and novel biomarkers. Biomolecules11(11), 1581 (2021).
   PubMed Web of Science ®Google Scholar
• Cui H , HuoG, LiuLet al. Association of cardiac and renal function with extreme N-terminal fragment pro-B-type natriuretic peptide levels in elderly patients. BMC Cardiovasc. Disord.12, 57 (2012).
   PubMed Web of Science ®Google Scholar
• Agarwal AK . Iron metabolism and management: focus on chronic kidney disease. Kidney Int. Suppl.11(1), 46–58 (2021).
   Web of Science ®Google Scholar
• van Swelm RP , WetzelsJF, VerweijVGet al. Renal handling of circulating and renal-synthesized hepcidin and its protective effects against hemoglobin-mediated kidney injury. J. Am. Soc. Nephrol.27(9), 2720–2732 (2016).
   PubMed Web of Science ®Google Scholar
• Min HK , OhYK, ChoiKHet al. Relationship between cardiac geometry and serum hepcidin in chronic kidney disease: analysis from the KNOW-CKD Study. J. Korean Med. Sci.35(1), e2 (2020).
   PubMed Web of Science ®Google Scholar
• Haase-Fielitz A , MertensPR, PlassMet al. Urine hepcidin has additive value in ruling out cardiopulmonary bypass-associated acute kidney injury: an observational cohort study. Crit. Care15(4), R186 (2011).
   PubMed Web of Science ®Google Scholar
• Haase-Fielitz A , PlaßM, KuppeHet al. Low preoperative hepcidin concentration as a risk factor for mortality after cardiac surgery: a pilot study. J. Thorac. Cardiovasc. Surg.145(5), 1380–1386 (2013).
   PubMed Web of Science ®Google Scholar
• Choi N , RigattoC, ZappitelliMet al. Urinary hepcidin-25 is elevated in patients that avoid acute kidney injury following cardiac surgery. Can. J. Kidney Health Dis.5, 2054358117744224 (2018).
   Google Scholar
• Ganz T , NemethE. Iron balance, and the role of hepcidin in chronic kidney disease. Semin. Nephrol.36(2), 87–93 (2016).
   PubMed Web of Science ®Google Scholar
• Paragas N , QiuA, ZhangQet al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat. Med.17(2), 216–222 (2011).
   PubMed Web of Science ®Google Scholar
• Mishra J , DentC, TarabishiRet al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet365(9466), 1231–1238 (2005).
   PubMed Web of Science ®Google Scholar
• Haase M , BellomoR, DevarajanPet al. NGAL Meta-analysis Investigator Group . Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis.54(6), 1012–1024 (2009).
   PubMed Web of Science ®Google Scholar
• Vasques-Nóvoa F , PedroFerreira J, MarquesPet al. Interleukin-6, infection, and cardiovascular outcomes in acute heart failure: findings from the EDIFICA registry. Cytokine160, 156053 (2022).
   PubMed Web of Science ®Google Scholar
• McGeough MD , PenaCA, MuellerJLet al. Cutting edge: IL-6 is a marker of inflammation with no direct role in inflammasome-mediated mouse models. J. Immunol.189(6), 2707–2711 (2012).
   PubMed Web of Science ®Google Scholar
• McCullough PA , BouchardJ, WaikarSSet al. Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol.182, 5–12 (2013).
   PubMed Web of Science ®Google Scholar
• Vahanian A , BeyersdorfF, PrazFet al. ESC/EACTS Scientific Document Group . 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev. Esp. Cardiol. (Engl. Ed.)75(6), 524 (2022).
   PubMed Web of Science ®Google Scholar
• Chang KW , HsuJC, ToomuA, FoxS, MaiselAS. Clinical applications of biomarkers in atrial fibrillation. Am. J. Med.130, 1351–1355 (2017).
   PubMed Web of Science ®Google Scholar
• Kappetein AP , HeadSJ, GénéreuxP, PiazzaN, van MieghemNM, BlackstoneEHet al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur. Heart J.33(19), 2403–2418 (2012).
   PubMed Web of Science ®Google Scholar
• Singer M , DeutschmanCS, SeymourCWet al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA315(8), 801–810 (2016).
   PubMed Web of Science ®Google Scholar
• Levey AS , StevensLA, SchmidCHet al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) . A new equation to estimate glomerular filtration rate. Ann. Intern. Med.150(9), 604–612 (2009).
   PubMed Web of Science ®Google Scholar
• Nashef SA , RoquesF, SharplesLDet al. EuroSCORE II. Eur. J. Cardiothorac. Surg.41, 734–744 (2012).
   PubMed Web of Science ®Google Scholar
• Cubeddu RJ , AsherCR, LowryAMet al. PARTNER Trial Investigators . Impact of transcatheter aortic valve replacement on severity of chronic kidney disease. J. Am. Coll. Cardiol.76(12), 1410–1421 (2020).
   PubMed Web of Science ®Google Scholar
• Lemes da Silva MV , NunesFilho ACB, RosaVEEet al. Improvement of renal function after transcatheter aortic valve replacement in patients with chronic kidney disease. PLOS ONE16(5), e0251066 (2021).
   PubMed Web of Science ®Google Scholar
• Jäckel M , KellerS, PragerEPet al. The impact of transcatheter aortic valve implantation planning and procedure on acute and chronic renal failure. Cardiol. J.30(2), 247–255 (2021).
   PubMed Web of Science ®Google Scholar
• Haase-Fielitz A , AltendeiteringF, IwersRet al. Acute kidney injury may impede results after transcatheter aortic valve implantation. Clin. Kidney J.14(1), 261–268 (2020).
   PubMed Web of Science ®Google Scholar
• Kato A . Increased hepcidin-25 and erythropoietin responsiveness in patients with cardio-renal anemia syndrome. Future Cardiol.6(6), 769–771 (2010).
   PubMedGoogle Scholar
• Kulaksiz H , TheiligF, BachmannSet al. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J. Endocrinol.184, 361–370 (2005).
   PubMed Web of Science ®Google Scholar
• Prowle JR , OstlandV, CalzavaccaPet al. Greater increase in urinary hepcidin predicts protection from acute kidney injury after cardiopulmonary bypass. Nephrol. Dial. Transplant.27, 595–602 (2012).
   PubMed Web of Science ®Google Scholar
• Ho J , ReslerovaM, GaliBet al. Urinary hepcidin-25 and risk of acute kidney injury following cardiopulmonary bypass. Clin. J. Am. Soc. Nephrol.6(10), 2340–2346 (2011).
   PubMed Web of Science ®Google Scholar